HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Virus and Cancer
Virus and Cancer
Viruses are microscopic 'organisms' that infect the cells of other animals and plants. Human cancer has been related to a number of viruses. When viruses cause an infection, their DNA spreads throughout the body, altering the genetic makeup of healthy cells and potentially leading to cancer. Viruses have been found to play a role in the biology of multistep oncogenesis and are linked to a number of cancer manifestations. Virus infections are thought to be responsible for 15–20 percent of all human cancers. Vaccines to help prevent specific human cancers have been developed as our knowledge of the role of viruses as a cause of cancer has expanded.
- Human tumor viruses
- Epstein-Barr virus (EBV)
- Human Papilloma Viruses (HPV)
- Hepatitis B virus (HBV)
- hepatitis C virus (HCV)
- Human immunodeficiency virus (HIV)
- Human herpes virus 8 (HHV-8)
- Other Oncogenic viruses
- Vaccines and Its Development
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Miri Cohen
University of Haifa, IsraelSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China